David N. Low
Independent DirectorMr. David N. Low, Jr. has been Director of ContraFect Corporation since April 2014. Mr. Low has worked as an investment banker since 1987, with broad investment and advisory experience in the life sciences, biotechnology and medical technology sectors. Since June 2017, Mr. Low has served as a partner at MTS Healthpartners, a healthcare investment banking boutique. From 2002 to April 2017, Mr. Low was a member of Lazard’s Life Sciences Group as a Managing Director and Senior Advisor. Mr. Low has advised on major M&A transactions in the life sciences, biotechnology and medical technology sectors, and has worked with private and public companies to raise capital, including emerging growth companies. Prior to joining Lazard, he was a Managing Director at JP Morgan Chase & Co. and a Senior Vice President at Lehman Brothers. Mr. Low serves on the board of directors of the We Teach Science Foundation (as Chairman), the Philharmonia Baroque Orchestra, and the French International School. Mr. Low built and led Lazard's San Francisco life sciences team. Significant transactions include Sumitomo Dainippon Pharma Co., Ltd.'s acquisition of Tolero Pharmaceuticals, Inc., the integration of Stallergenes, S.A. and Ares Life Sciences' Greer Laboratories Inc., Amgen Inc.'s acquisition of Onyx Pharmaceuticals, Inc. Mr. Low holds an A.B. from Harvard College, where he graduated cum laude, an M.A. from the Johns Hopkins University School of Advanced International Studies and an M.B.A. from Yale University.
Positions
- Company NameContraFect CorporationStock CodeCFRXQPositionIndependent DirectorColleagues
- MMMichael MessingerCEO, President, CFO & Principal Accounting Officer
- RJRoger James PomerantzChairman
- NBNatalie BogdanosGeneral Counsel, Corporate Secretary & Data Protection Officer
- MSMatthew SalamoneVice President of Human Resources
- GWGary WoodnuttSenior Vice President of Translational Sciences & Preclinical Development
- WGWilliam Garrett NicholsInterim Chief Medical Officer
- SCSteven C. GilmanVice Chairman
- VAVincent A. FischettiChairman of Scientific Advisory Board
- SJSol J. BarerLead Independent Director
